Clinical Research Directory

Inclusion Criteria: * Aged 21-85 years (inclusive) * Diagnosed with OSA, Established on PAP therapy for ≥90 days at the time of consent * Currently prescribed and using fixed pressure, Auto CPAP, or BiPAP therapy on a regular basis (average PAP usage of ≥4 hours/night, ≥4 days per week for ≥3 months) * Able to read, write, speak and understand English * Willing and able to provide informed consent * Willing and able to follow instructions and complete all activities required by the study * Able to remove a sleep apnea mask without assistance * Currently using a ResMed PAP therapy device with a connection to ResMed's AirView system * Currently using ResMed AirFit F20 Exclusion Criteria: * Significant risk of aspiration (i.e., active vomiting or taking a prescription drug that induces vomiting) * Known allergy to silicone, latex, polyamide (nylon), spandex, polyurethane, acetal, polycarbonate, or polypropylene * Active infection or inflammation in an area in contact with the mask * Recent head or facial surgery unless cleared by a healthcare provider to resume regular therapy * Planned head or facial surgery during the study * Any congenital or acquired craniofacial malformations or abnormalities, acute trauma, or burns that would interfere with the mask's placement or ability to deliver therapy * Employee or family member who works for Philips or any of its direct competitors in the sleep industry * Prescribed oxygen at night or continuously * Currently participating in another interventional research study or planned participation in another interventional clinical research study during the trial period * Prescribed an ASV (adaptive servo-ventilation) device * Prescribed mechanical ventilation * Pre-existing conditions such as bullous lung disease, pathologically low blood pressure, bypassed upper airway, pneumothorax, pneumocephalus, cerebral spinal fluid (CSF) leaks, * Any unstable medical condition (e.g., uncontrolled cardiac, lung, or neurological disease) or limitation that would affect the participant's ability to complete trial activities * Experiencing any acute illness (e.g., acute sinusitis, ear or eye infections, upper respiratory infections, pharyngitis, bronchitis, pleurisy, pneumonia, or facial dermatitis) that would impact their ability to use the mask and/or PAP therapy during the trial * Pregnant (self-report) * Advised by a health care provider to avoid magnets * Patient or patient's household member, caregiver or bed partner in close vicinity that have implanted devices that may be affected by magnets, including but not limited to: * Pacemakers * Implantable cardioverter defibrillators (ICD) * Neurostimulators * Magnetic metallic implants/electrodes/valves placed in upper limbs, torso, or higher (i.e., neck and head) * Cerebral spinal fluid (CSF) shunts (e.g., ventriculo peritoneal (VP) shunt) * Aneurysm clips * Embolic coils * Intracranial aneurysm intravascular flow disruption devices * Metallic cranial plates * Screws, burr hole covers, and bone substitute devices * Metallic splinters in the eye * Ocular implants (e.g., glaucoma implants, retinal implants) * Certain contact lenses with metal * Implants to restore hearing or balance that have an implanted magnet (such as cochlear implants, implanted bone conduction hearing devices, and auditory brainstem implants * Magnetic denture attachments * Metallic gastrointestinal clips * Metallic stents (e.g., aneurysm, coronary, tracheobronchial, biliary) * Implantable ports and pumps (e.g., insulin pumps) * Hypoglossal nerve stimulators * Implanted devices labeled as MR (magnetic resonance) unsafe * Magnetic metallic implants not labeled for MR or not evaluated for safety in a magnetic field * Paralysis of the hemi-diaphragm